RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 08 09 2024
revised: 17 09 2024
accepted: 18 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that induces cytokine hypersecretion. Receptor activity-modifying protein (RAMP) 1, a subunit of the calcitonin gene-related peptide (CGRP) receptor, regulates the production of cytokines. This study examined the role of RAMP1 signaling during lipopolysaccharide (LPS)-induced acute lung injury (ALI). LPS administration to wild-type (WT) mice depleted alveolar macrophages (AMs) and recruited monocyte-derived macrophages (MDMs) and neutrophils. RAMP1-deficient (RAMP1

Identifiants

pubmed: 39337592
pii: ijms251810107
doi: 10.3390/ijms251810107
pii:
doi:

Substances chimiques

Receptor Activity-Modifying Protein 1 0
Lipopolysaccharides 0
Cytokines 0
Ramp1 protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Atsushi Yamashita (A)

Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.
Department of Anesthesiology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Yoshiya Ito (Y)

Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Mayuko Osada (M)

Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.
Department of Emergency and Critical Care Medicine, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Hiromi Matsuda (H)

Department of Anesthesiology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Kanako Hosono (K)

Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Kazutake Tsujikawa (K)

Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Hirotsugu Okamoto (H)

Department of Anesthesiology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Hideki Amano (H)

Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, Japan.
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara 252-0374, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH